News Related to Type 1 Diabetes Mellitus

Related coverage linked through entity extraction aliases.

Tandem Diabetes Wins CE Mark for AID Systems in Europe After FDA Pregnancy Approval

Jun 05, 2026

Tandem Diabetes Care secured expanded CE mark approval in Europe for its Control-IQ automated insulin delivery systems, covering adults with type 2 diabetes and type 1 diabetes during pregnancy. The approvals follow FDA clearance in the US and are supported by clinical trial data showing improved glucose control.

Nektar Therapeutics Closes $460 Million Public Offering with Full Underwriter Exercise

Feb 14, 2026

Nektar Therapeutics completed a $460 million public offering on February 13, 2026, selling 7.6 million shares of common stock and pre-funded warrants. The clinical-stage biotechnology company is developing immunotherapy treatments for autoimmune diseases.